HomeInsightsStock Comparison

Acutaas Chemicals Ltd vs Sakar Healthcare Ltd Stock Comparison

Acutaas Chemicals Ltd vs Sakar Healthcare Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Ami Organics Ltd is ₹ 1104 as of 13 Jun 15:30.
  • The P/E Ratio of Ami Organics Ltd changed from 50.6 on March 2022 to 94.3 on March 2024 . This represents a CAGR of 23.06% over 3 yearsThe P/E Ratio of Sakar Healthcare Ltd changed from 7.8 on March 2020 to 68.6 on March 2024 . This represents a CAGR of 54.47% over 5 years.
  • The Market Cap of Ami Organics Ltd changed from ₹ 3642 crore on March 2022 to ₹ 4036 crore on March 2024 . This represents a CAGR of 3.48% over 3 yearsThe Market Cap of Sakar Healthcare Ltd changed from ₹ 74.73 crore on March 2020 to ₹ 801.05 crore on March 2024 . This represents a CAGR of 60.71% over 5 years.
  • The revenue of Ami Organics Ltd for the Mar '25 is ₹ 314.26 crore as compare to the Dec '24 revenue of ₹ 276.66 crore. This represent the growth of 13.59% The revenue of Sakar Healthcare Ltd for the Mar '25 is ₹ 50.42 crore as compare to the Dec '24 revenue of ₹ 43.71 crore. This represent the growth of 15.35%.
  • The ebitda of Ami Organics Ltd for the Mar '25 is ₹ 90.74 crore as compare to the Dec '24 ebitda of ₹ 70.34 crore. This represent the growth of 29% The ebitda of Sakar Healthcare Ltd for the Mar '25 is ₹ 15.91 crore as compare to the Dec '24 ebitda of ₹ 12 crore. This represent the growth of 32.58%.
  • The net profit of Ami Organics Ltd changed from ₹ 22.24 crore to ₹ 62.72 crore over 8 quarters. This represents a CAGR of 67.93% The net profit of Sakar Healthcare Ltd changed from ₹ 2.84 crore to ₹ 5.76 crore over 8 quarters. This represents a CAGR of 42.41% .
  • The Dividend Payout of Ami Organics Ltd changed from 15.19 % on March 2022 to 25.33 % on March 2024 . This represents a CAGR of 18.58% over 3 yearsThe Dividend Payout of Sakar Healthcare Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ami Organics Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

About Sakar Healthcare Ltd

  • Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
  • Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
  • The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
  • It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

Ami Organics Ltd News Hub

News

Board of AMI Organics recommends final dividend

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2...

Read more

02 May 2025 14:08

News

Ami Organics jumps after Q4 PAT soars to Rs 627 cr

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter e...

Read more

02 May 2025 14:49

News

AMI Organics to hold board meeting

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025. P...

Read more

25 Apr 2025 11:18

News

Ami Organics' Unit II receives Japan PMDA nod for GMP compliance

Ami Organics' manufacturing facility, Unit II situated at Ankleshwar, which is involved in...

Read more

24 Apr 2025 15:57

News

AMI Organics to hold EGM

AMI Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

16 Apr 2025 20:44

News

Board of Ami Organics approves change in company name to Acutaas Chemicals

The Board of Ami Organics at its meeting held on 16 April 2025 has approved the change in ...

Read more

16 Apr 2025 15:03

Sakar Healthcare Ltd News Hub

News

Sakar Healthcare to discuss results

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 15 May 20...

Read more

10 May 2025 11:14

News

Sakar Healthcare to conduct board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 8 Februar...

Read more

03 Feb 2025 10:50

News

Sakar Healthcare schedules board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 22 Octobe...

Read more

18 Oct 2024 16:55

News

Sakar Healthcare to hold board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 13 August...

Read more

09 Aug 2024 16:37

News

Sakar Healthcare to convene AGM

Sakar Healthcare announced that the 20th Annual General Meeting (AGM) of the company will ...

Read more

23 Jul 2024 10:02

News

Sakar Healthcare to convene board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 21 May 20...

Read more

15 May 2024 16:27

SWOT Analysis Of Ami Organics Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sakar Healthcare Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ami Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sakar Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ami Organics Ltd and Sakar Healthcare Ltd

Which company has a larger market capitalization, Ami Organics Ltd or Sakar Healthcare Ltd?

Market cap of Ami Organics Ltd is 9,039 Cr while Market cap of Sakar Healthcare Ltd is 687 Cr

What are the key factors driving the stock performance of Ami Organics Ltd and Sakar Healthcare Ltd?

The stock performance of Ami Organics Ltd and Sakar Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ami Organics Ltd and Sakar Healthcare Ltd?

As of June 14, 2025, the Ami Organics Ltd stock price is INR ₹1104.15. On the other hand, Sakar Healthcare Ltd stock price is INR ₹313.3.

How do dividend payouts of Ami Organics Ltd and Sakar Healthcare Ltd compare?

To compare the dividend payouts of Ami Organics Ltd and Sakar Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions